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Abstract A variety of conditions other than acute
myocardial infarction may cause ST-elevation. Our
objective was to evaluate the impact of cardiac
magnetic resonance (CMR) on differential diagnosis
from a prospective series of patients with suspected
ST-elevation myocardial infarction (STEMI) and
completely normal coronary arteries. Among 1,145
patients with suspected STEMI, 49 patients had
completely normal coronary arteries and entered a
prospective registry. CMR was done within 24 h, if
possible, and included function analyses, T2-weighted
imaging (T2 ratio), T1-weighted imaging before and
after gadolineum administration (global relative
enhancement; gRE), and late gadolineum enhance-
ment (LGE). All patients were asked for a follow-up
CMR after approximately 3 months. The incidence of
patients with suspected STEMI and normal coronary
arteries was 4.3% and mean age was 45 ± 14 years
(STEMI group 64 ± 13 years; P\0.001). 55% had a
recenthistoryofinfection.Cardiacbiomarkersshowed
a moderate elevation on admission. There was a
signiﬁcant change from baseline to follow-up for LV
end-diastolic volumes (EDV) (P\0.001), LV mass
(P\0.05), mean T2 ratio (P\0.05), and LGE
volume (P\0.05). Major diagnostic groups were
myocarditis (29%), pericarditis (27%), and takotsubo
cardiomyopathy (10%). 18% were regarded as non-
diagnostic. The study showed an incidence of 4.3% of
patientswithsuspectedSTEMIandcompletelynormal
coronary arteries. Early CMR was valuable in the
evaluation of the differential diagnoses and to exclude
myocardial abnormalities in patients with uncertain
aetiology. Further studies are needed for the assess-
ment of long-term outcome.
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Introduction
Standard 12-lead electrocardiogram (ECG) is a key
diagnostic tool to direct patients with suspected acute
myocardial infarction to the angiography suite [1].
However, a variety of other serious conditions aside
from acute myocardial infarction may also cause
ST-elevation, including pericarditis, myocarditis,
cardiomyopathy, cardiac contusion, congestive heart
failure, and non-cardiac causes including pulmonary
embolism, septicaemia, renal failure, and aortic
dissection [2, 3]. Various series of such patients have
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the condition is still a source of debate. Also, this
cohort of patients has been shown to have a poor
prognosis [4]. The combination of ECG and bio-
markers has been used to determine the extent and
location of myocardial injury; however, current
diagnostic approaches may have limitations.
In order to establish the underlying cause for the
ECG abnormality, CMR offers a potential opportu-
nity due to its ability to identify myocardial oedema
and inﬂammation, as well as scarring associated with
myocardial infarction [5]. Due to the high spatial
resolution and introduction of gadolinium contrast,
CMR is being used for a growing number of clinical
applications. A multisequential approach has been
shown to be promising for the detection of non-
ischemic conditions, such as myocarditis [6]. Thus,
we aimed to evaluate the impact of CMR on
differential diagnosis from a prospective series of
patients with suspected STEMI and completely
normal coronary arteries using a combination of
available sequences [7].
Materials and methods
Our hospital is a tertiary care institution, which for
the last 3 years approximately have admitted 800
STEMI patients per year. All patients 18–75 years
old with chest pain \24 h, signiﬁcant ST-elevation,
new left bundle-branch block, and completely normal
coronary arteries at angiography were included.
Patients with visible lumen irregularities, spasm, or
thrombus on standard coronary angiography, and/or
prior percutaneous coronary intervention (PCI), were
excluded (n = 2). However, provocative tests for the
exclusion of coronary spasm were not performed.
Included patients entered into a prospective registry
that included a repeat 12-lead ECG, history, clinical
examination, blood tests, chest x-ray, echocardiogra-
phy, and CMR. ST-segment elevation was deﬁned as
J-point elevation[1 mm in leads II, III, aVF, I, aVL,
and/or [2 mm in leads V1-6, with a total of
minimum 2 mm in the inferior leads, and/or 4 mm
in the anterior leads. History of angina was recorded
according to the CCS classiﬁcation. The blood tests
included troponin-T, creatine kinase-myocardial band
(CK-MB), probrain natriuretic peptide (proBNP), and
C-reactive proteine (CRP). The CMR was performed
as soon as the clinical situation allowed it, if possible
within 24 h. Further investigations, such as computer
tomography (CT), were done when needed to estab-
lish a diagnosis. All patients were asked for a follow-
up, which included a repeat ECG, biomarkers, and
CMR.
Patients were excluded from CMR if they had
contraindications for CMR at study entry such as
implanted pacemakers (n = 0) or severe claustropho-
bia (n = 3), or contrast media associated contraindi-
cations like renal insufﬁciency (n = 0). All patients
signed an informed consent to enter the study. The
study was approved by the Regional Ethics Commit-
tee and Review Board of our institution.
CMR imaging protocol
The CMR studies were performed by using a 1.5-Tesla
unit (Intera CV, Philips Medical Systems, Best, The
Netherlands). A standard ﬁve-channel phased-array
cardiac coil was used, and a signal correction
shimming technique was used to compensate for
possible inhomogeneity of the ﬁeld. If repositioning
of the patient was needed, the entire sequence was
repeated. For functional analysis ECG-gated steady
state free precession (SSFP) cine images were
acquired in the two-chamber and four-chamber
views, as well as sequential 10 mm short-axis slices
from the atrio-ventricular ring to the apex (TE
1.9 ms, TR 3.8 ms, ﬂip angle 60). T2 weighted
breath-hold black-blood triple inversion images were
acquired in the same short axis plane (TE 80 ms, TR
2 9 R-R interval, TI 180 ms, slice thickness 10 mm,
ﬂip angle 180, pixel size 0.96 9 0.96 mm). After
an i.v. bolus of 0.15 mmol/kg gadolineum-
diethylenetriaminepentaacetate (Gd-DTPA, Magnevist,
Schering, Germany), a short axis T1 weighted
gradient echo inversion-recovery (IR) early (global)
relative enhancement sequence (gRE) (TR 1 9 R-R
interval, TE 20 ms, slice thickness 10 mm) was
performed. Measurements started immediately after
injection of Gd-DTPA (automated injector, Medrad,
Indianola, USA) and lasted for 3–4 min (without any
change of parameters in between). Finally, late
gadolineum enhancement (LGE) images in the short
and long axis views were acquired after 15 min,
using a similar gradient echo IR sequence. Inversion
times were adjusted to null normal myocardium using
the Look-Locker sequence.
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Off-line analyses were performed on a dedicated
workstation (ViewForum release 5.2, Philips Medical
Systems, Best, The Netherlands). Ventricular vol-
umes and function were measured for both ventricles
using standard techniques. The endocardial and
epicardial borders were drawn manually on each
dynamic image. The LV ejection fraction (EF), end
diastolic volume (EDV), systolic wall thickening
(SWT), and myocardial mass were calculated from
the short axis (SA) views. The right ventricle (RV)
EF was calculated from the four-chamber view. Two
blinded experienced readers (KHS, PH; both 14 years
of experience) examined the T2, gRE, and LGE
images, and differences in interpretation were
resolved in an additional consensus reading.
Visualization of myocardial oedema was per-
formed using the T2-weighted sequence by measur-
ing the ratio of global myocardial signal intensity
to skeletal muscle. Depending on the homogeneity,
the skeletal muscle signal intensity (SI) was drawn
on the same slice. The T2-ratio was calculated as SI
myocardium/SI skeletal muscle, and according to our
own validation a T2 ratio of 2.0 was used as cutoff
value. The early gadolineum enhancement sequence
was measured in a similar way, and regions of
interest were copied from the pre-contrast to the post-
contrast images. The gRE was calculated as previ-
ously described by Friedrich [8], and a cutoff value of
4 or higher was used. The LGE sequence was
analyzed segment by segment (17 segments), and the
total volume of enhancement was calculated ([2
standard deviations (SD) compared to a normal or
non-enhancing segment) [9]. The LGE was described
as either epimyocardial or centromyocardial, a loca-
tion associated with myocarditis. The CMR was also
analysed for the presence of concomitant pleural and
pericardial effusion, and/or enhancement of the
pericardial layers.
Control group
For validation of CMR sequences and determination
of imaging speciﬁc cutoff values, 13 healthy volun-
teers (8 males, 5 females, 39 ± 12 years) with no
current or past evidence of cardiovascular disorders
underwent the CMR protocol. We also used the
validation process to secure sufﬁcient homogeneity
with the use of the surface coil and signal intensity
correction software.
Statistical analysis
Each categorical variable is expressed as number and
percentage of patients. Demographical and clinical
data are presented as mean with SD or proportions.
Baseline characteristics were compared between
subgroups using an independent sample t-test or
Mann–Whitney test as appropriate. A Fischer’s exact
or chi-square test for contingency tables was obtained
to detect associations between categorical indepen-
dent variables. When comparing continuous vari-
ables, a two-sided Student’s t test was used. P values
less than 0.05 were considered statistically signiﬁ-
cant, and P values less than 0.001 highly signiﬁcant.
All statistical analysis was performed using Graph-
Pad Prism for Macintosh, version 5.0 (GraphPad
Software, La Jolla, CA, USA).
Results
During an 18 months period in 2007 and 2008, 1,145
patients were referred to our hospital with suspected
STEMI. Without testing for coronary spasm, 49
patients had normal coronary arteries (4.3%) and all
were willing to participate in the study. The baseline
characteristics are summarized in Table 1. The mean
age of the cohort was 45 ± 14 years, while the mean
age in the STEMI group in the same period was
64 ± 13 years (P\0.001). 12% of the patients were
females, compared to 25% (n = 288) in the STEMI
group (P\0.001). The median time from coronary
angiography to CMR was 20 ± 14 h. Follow-up was
done in 86% of the patients after 100 ± 20 days and
ﬁnished by the end of 2009. There was a low
prevalence of cardiac risk factors, and only two
patients had diabetes mellitus and three patients a
prior history of angina (CCS class I–II). 19 (38.8%)
patients were regular smokers and 12 (24.5%)
patients had hypertension, in addition two patients
were regular users of cannabis. 27 (55%) patients had
a recent history of infections; most common was
respiratory tract infections or ﬂu-like symptoms,
either as a direct viral infection or a post-viral
immune-mediated reaction.
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123ECG on admission showed anterior ST-elevation in
47%ofthepatients,andcombinedanteriorandinferior
ST-elevation in 49% of the patients. No patients
presentedwithinferiorST-elevationalone.ST-depres-
sion was seen in 10% of the patients, and T-inversions
in 12%. All patients had QT and PQ times within
normal range. All ECG changes normalized at follow-
up, except from persistent T-inversions in 5% of the
patients. Both cardiac biomarkers and CRP showed
moderate elevation, however, all biomarkers normal-
ized at follow-up (P\0.001). 43 (88%) patients had
an echocardiography done, and mean EF on admission
was 57.5%. No patients required electrical cardiover-
sion,andnonehadpre-existingrenalimpairment.Nine
patients were on primary prevention therapy, with
statins being the most common treatment.
Segmental analysis of the T2 and gRE sequences
in volunteers showed\5% signal differentiation, we
therefore decided to use the surface coil with signal
correction software. CMR results are shown in
Table 2. There was a signiﬁcant change from base-
line to follow-up for LV end-diastolic volumes
(EDV) (156.2 ± 28.1 ml vs. 137.1 ± 25.4; P\
0.001), LV mass (131.2 g ± 26.2 vs. 117.4 ± 27.0;
P\0.05), mean T2 ratio (1.86 ± 0.26 vs. 1.71 ±
0.28; P\0.05), and LGE volume (12.2 ± 11.4 g vs.
5.9 ± 19.9; P\0.05). LGE was seen most fre-
quently in segments 4, 5, 6, 11, 12, and 16. No sig-
niﬁcant change was associated with LV EF, LV
SWT, RV EF, or gRE. Mean T2 ratio was also
signiﬁcantly higher at baseline versus the control
group (P\0.05). Pleural effusion (n = 4) and peri-
cardial effusion (n = 5) seen on admission were
normalized in all patients at follow-up. Mitral valve
regurgitations (n = 2) and tricuspid valve regurgita-
tion in one patient with reduced RV function on
admission were also normalized at follow-up.
Table 1 Baseline characteristics
Characteristics Value (n = 49)
Mean age, years 45.0 ± 14.0
Male sex (%) 45 (91.8)
Family history of CVD (%) 20 (40.8)
Angina (%) 3 (6.1)
Diabetes (%) 2 (4.1)
Hypertension (%) 12 (24.5)
Smoking (%) 19 (38.8)
BMI[30 (%) 3 (6.1)
Drug abuse (%) 2 (4.1)
Recent infection
Respiratory tract (%) 14 (28.6)
Flu-like symptoms (%) 10 (20.4)
Other (%) 3 (6.1)
Electrocardiographic changes
Anterior ST-elevation (%) 23 (46.9)
Anterior and inferior ST-elevation (%) 24 (49.0)
T-inversion (%) 6 (12.2)
Mean anterior ST-elevation, mm 6.3 ± 3.7
Mean inferior ST-elevation, mm 1.8 ± 2.5
Biomarkers
CK-MB (mg/1) 22.5 ± 45.8
Troponin-T (lg/1) 0.48 ± 0.87
proBNP (pmol/1) 106.5 ± 272.9
CRP (mg/1) 53.4 ± 77.5
Echocardiography (n = 43)
Mean EF (%) 57.5 ± 7.5%
EF\50%, n (%) 5 (11.6%)
Medication on admission
ACE-1/AT-II blocker, n (%) 7 (14.3)
Beta-blocker, n (%) 5 (10.2)
Statins, n (%) 9 (18.4)
None, n (%) 28 (57.1)
Table 2 CMR ﬁndings at baseline and follow-up
Baseline Follow-up P-value
LV EF (%) 58.2 ± 10.8 61.0 ± 7.9 NS
LV EDV (ml) 156.2 ± 28.1 137.1 ± 25.4 \0.001
LV SWT (%) 73 ± 32 79 ± 27 NS
LV mass (g) 131.2 ± 26.2 117.4 ± 27.0 \0.05
RV EF (%) 63.3 ± 9.6 64.4 ± 10.0 NS
Elevated
T2 ratio, n (%)
17 (39.5) 5 (13.5) \0.001
Mean T2 ratio 1.86 ± 0.26* 1.71 ± 0.28 \0.05
Elevated
gRE, n (%)
5 (11.6) 4 (10.8)
Mean gRE 3.05 ± 1.25 2.79 ± 0.88 NS
LGE, n (%) 14 (32.6) 5 (13.5) \0.001
Mean LGE
volume (g)
12.2 ± 11.4 5.9 ± 19.9 \0.05
Pleural effusion,
n (%)
4 (9.3) 0 \0.001
Pericardial
effusion, n (%)
5 (11.6) 0 \0.001
* P\0.05 vs. the control group
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The patients were grouped according to their ﬁnal
diagnosis, using an integrated approach of clinical
ﬁndings, ECG, biomarkers and CMR. Based on these
ﬁndings, all patients were classiﬁed into 7 groups,
which are listed in Table 3. 14 patients (29%) were
classiﬁed as myocarditis (Fig. 1a–d). In addition to
acute chest pain and ECG changes, these patients also
hadelevationoftroponin-Tand/orCK-MB,and‘‘2out
of 3’’ abnormal sequences on CMR (T2, gRE, LGE)
[9]. 5 patients had persistent LGE at follow-up. 13
patients (27%) were classiﬁed as pericarditis (Fig. 2a–d)
[10]. In addition to chest pain (pericarditic), these
patients also showed widespread (upward concave)
ST-segment elevation, 85% showed elevation of CRP,
and39%hadpericardialeffusion,however,nopatients
in this subgroup showed elevation of cardiac biomark-
ers during the initial hospital stay. One patient showed
additional hyperintense signal from the pericardium
on T2-weighted images and hyperenhancement on
the LGE images at follow-up. 5 patients (10%)
were classiﬁed as Takotsubo cardiomyopathy (TTC)
(Fig. 3a–d), also called stress cardiomyopathy or
ventricular ballooning syndrome, and the diagnosis
was based on the modiﬁed Mayo Clinic criteria [11].
No abnormal signal activity was documented on the
LGE sequence. TTC was conﬁrmed when there was a
complete normalization of LV EF at follow-up.
2 patients (4%) with increased end-diastolic volumes
and reduced systolic function, and without other CMR
abnormalities, were categorized as dilated cardiomy-
opathy (DCM) (Fig. 4a–d) [12]. Nine patients (18%)
with normal range volumes, no CMR abnormalities,
normal clinical ﬁndings, and normal biomarkers both
at discharge and follow-up, were considered non-
diagnostic.However,5(10%)patientswithamoderate
troponin-T elevation (0.38 ± 0.32) as the only ﬁnd-
ing, and one patient with a phaeochromocythoma
(Fig. 5a, b), were classiﬁed in separate groups. No
patients showed any signs of myocardial infarction at
CMR, neither at baseline nor at follow-up.
Some signiﬁcant differences were seen between the
groups. Compared to the control group, at baseline the
LVEF was signiﬁcantly lower in the myocarditis
(P\0.05) and the TTC groups (P\0.05), the T2
ratio was higher in the myocarditis (P\0.001) and
TTC groups (P\0.05), and the SWT was lower in
the TTC group (P\0.05). There were no signiﬁcant
differences regarding RV EF, LV EDV, LV mass, or
gRE compared to the control group. Compared to
reference values, CK-MB, troponin T, and proBNP
were elevated in the myocarditis group (P\0.05),
and Troponin T was elevated in the TTC group
(P\0.05). CRP was elevated in the pericarditis
(P\0.05) and myocarditis groups (P\0.05).
Other clinical investigations
Depending on the clinical presentation, biomarkers,
and CMR, some patients were additionally investi-
gated. All patients with persistent LGE at follow-up
had an additional CMR approximately 12 months
after the acute event that showed a complete normal-
ization in all, except a mild lateral myocardial scarring
in one patient. CT pulmonary angiography was
performed in ﬁve patients with elevated D-dimer,
but did not show evidence of embolism. One patient
had an abdominal CT performed, which conﬁrmed the
suspicion of an adrenal tumor, and the patient was
successfully operated for a pheochromocytoma [13].
Another patient had a thoracic CT performed and a
right side pulmonary tumor was identiﬁed, conﬁrming
the suspicion from CMR. No patients had a suspicion
of aortic dissection from the CMR examinations.
Discussion
Twelve-lead ECG and cardiac biomarkers are basic
tools in the diagnosis of acute myocardial infarction
in patients with chest pain. However, patients with
suspected STEMI and completely normal coronary
angiography present a clinical dilemma. Further
Table 3 Differential diagnosis
Diagnosis n = 49 Mean age
(SD), years
Myocarditis (%) 14 (28.6) 36.5 ± 13.9
Pericarditis 13 (26.5) 45.5 ± 14.7
Takotsubo cardiomyopathy 5 (10.2) 63.5 ± 4.6
DCM 2 (4.1) 36.6 ± 9.7
Phaeochromocythoma 1 (2.0) 51.3
Raised troponin 5 (10.2) 39.6 ± 16.2
Non diagnostic 9 (18.4) 43.2 ± 8.7
STEMI, same period 64.0 ± 13.1*
* P\0.001 vs. the study group
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and to direct treatment strategies. CMR has become a
valuable tool with the introduction of new sequences
with high spatial resolution, and therefore has a
potential role in the evaluation of aetiologies in
patients with suspected STEMI and completely
normal coronary arteries.
This study revealed an incidence of patients with
suspected STEMI and normal coronary arteries of
4.3%. Previous reports have shown a prevalence of
2.6–12% [14–16]. The study may indicate that these
patients often are younger men, who are less likely to
have traditional risk factors for atherosclerosis, than
are patients with documented coronary disease. Also,
these patients may have frequent viral infections and
stress symptoms (emotional and physical) prior to
admission. Hypertension was documented in 25% and
smoking in 53% of the patients. It is feasible that
smoking may have a contributory role in the patho-
genesis of this patient cohort, possibly via endothelial
dysfunction and coronary artery spasm [17].
The study demonstrated that CMR, in addition to
clinical ﬁndings and biomarkers, provided informa-
tion in a high percentage of our patients with
suspected STEMI and normal coronary arteries. The
most common cause was myocarditis (29%), fol-
lowed by pericarditis (27%), and takotsubo cardio-
myopathy (10%). This ﬁnding is in keeping with
other studies [18–20], although most other studies are
retrospective. CMR was able to detect acute myo-
cardial oedema in 40% of the patients, and the
normalization of initially increased T2-ratios corre-
sponded with a reduction of LV mass. In myocarditis
the myocardial injury often proceeds from a focal to a
global pattern [8], and the increase of myocardial
oedema is rapid and transient [21]. This is one of the
reasons why we performed a multisequential CMR
approach early after admission. The early enhance-
ment sequence (gRE), or the capillary leak phase,
was not of diagnostic importance in a majority of the
patients. However, serial studies demonstrate that
gRE needs a longer time delay after the onset of
Fig. 1 Short axis views of patient with myocarditis in the lateral wall. Images show oedema on the T2-weighted sequence (white
arrows)( a), increased gRE (b) and epicardial LGE (c). Follow-up shows normalization of LGE (d)
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[8], this is also shown in TTC patients [22]. Also
importantly, signiﬁcant infarction or ﬁbrosis was
excluded in a majority of our patients.
In the subset with myocarditis, 93% showed
evidence of acute myocardial oedema as indicated
by T2 imaging, and epicardial or centromyocardial
LGE was seen in all of the patients. The location of the
LGE allowed to distinguishing them from myocardial
infarction, which is important because of different
treatment strategies. Also, myocardial involvement as
demonstrated by T2 imaging and LGE in addition to
elevated cardiac biomarkers, allowed differentiating
myocarditis from pericarditis, which is a challenge in
clinical practice because they share common aetio-
logical agents. Previous work has demonstrated that
areas of LGE correlate well with biopsy ﬁndings when
the site of tissue sampling is guided by the CMR
ﬁndings [23]. Moreover, studies in such patients
demonstrate regression of these pathological changes
over time in a proportion of patients [8]. In the present
study, 86% of the myocarditis patients showed
complete resolution of the myocardial oedema after
a period of 106 days and 36% showed persistent LGE,
however, a repeat scanning after 350 days showed
scarring in only one patient. These ﬁndings may
underline the importance of both early and late CMR
in myocarditis patients.
Comparable data on the prevalence of pericarditis
is limited. The high percentage of pericarditis patients
within our patient cohort might be explained by the
short time delay between the onset of symptoms and
CMR. Previous reports that have documented a longer
time delay have shown a higher prevalence of patients
Fig. 2 4-chamber views of patient with pericarditis. Func-
tional images demonstrate normal ventricular function (a end-
diastolic, b end-systolic) with additional pleural- and
pericardial effusion, and a normal LGE sequence (c). Follow-
up shows unchanged normal ventricular function with no
effusion (d end-diastole)
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of TTC demonstrates the additional role of CMR in a
disease entity that is being increasingly recognized.
The therapy strategies are different from what might
have been the result based on ECG and angiography
alone. All patients in this group showed signiﬁcant
myocardial oedema as indicated by T2 imaging. The
acute reduction of LVEF and moderately elevated
cardiac biomarkers has been shown in several reports
[22, 24]. Two patients had dilated cardiomyopathy,
which may present with different ECG changes [19].
Five patients had a moderate troponin elevation as the
only ﬁnding and were classiﬁed in a separate group.
One patient had a tachyarrhythmia at presentation,
which possibly resulted in a raised troponin. Another
patient had a single elevated troponin test that was not
repeated in 24 h, and a ‘‘false positive’’ test was
considered a possibility [19].
28% of the patients had no ﬁnal diagnosis at
discharge or at follow-up. One possible explanation is
that CMRs limited resolution might not be high
enough to detect minor changes in myocardial
oedema and inﬂammation. Microinfarctions and dif-
fuse myocardial necrosis might be overseen for the
same reason. Other explanations may require other
imaging techniques, such as intravascular ultrasound.
Bounhoure et al. [25] recently showed that many
‘‘normal’’ angiograms revealed atherosclerotic pla-
ques, other mechanisms were coronary spasm and
myocardial bridge. Among other possible causes for
ST-elevation and normal coronary arteries that were
not identiﬁed in this study were aortic dissection,
Fig. 3 4-chamber views of patient with Takotsubo cardiomy-
opathy. Functional images demonstrate apical ballooning
(a end-diastole, b end-systole), and mitral valve insufﬁciency
(black arrow), in addition to apical myocardial oedema on the
T2-weighted sequence (increased T2 ratio) (white arrows)( c).
Follow-up shows complete normalization of ventricular
dysfunction (d end-systole)
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our experience that these diagnoses have to be
assessed in daily routines. We have recently shown
that both aortic dissection [26] and syndrome X [27]
might be represented by various ECG changes
including ST-elevation.
Limitations
A limitation of the current analysis is the relatively
small number of patients, although our study is large
compared to previous prospective reports. The lack of
endomyocardial biopsy (EMB) is a certain limitation
Fig. 4 4-chamber views of patient with DCM. Functional images demonstrate increased LVEDV and reduced EF (a end-diastole,
b end-systole), in addition to a normal T2-weighted (c) and LGE sequence (d)
Fig. 5 Patient with phaeochromocytoma. Coronal CT image demonstrate tumor of the left adrenal gland (a)( white arrows).
Functional images (long axis view) demonstrate apical ballooning (b end-systole) in the same patient
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limited [23], and EMB may have severe complica-
tions. Also, the majority of our patients were young
with an excellent prognosis, and we avoided unnec-
essary risks for the patients. There is a theoretical
possibility that some patients suffered from unde-
tected coronary heart disease, such as a resolved
thrombus, but the lack of scarring by CMR makes an
ischemic injury unlikely. Also, there is a possibility
that some patients had undetected coronary spasm
due to the lack of provocative tests. Ong showed that
in patients with acute coronary syndromes and
unobstructed coronary arteries, coronary spasm was
veriﬁed by acetylcholine provocation in nearly 50%
of the patients [28].
Conclusion
In conclusion, this prospective study revealed an
incidence of 4.3% of patients with suspected STEMI
but completely normal coronary arteries. Early CMR
was valuable in the evaluation of the major diagnoses
and to exclude myocardial abnormalities in patients
with uncertain aetiology. Therefore, CMR is able to
facilitate guidance of medical therapy in many of
these patients; however, further studies are needed for
the assessment of long-term outcome.
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